What You Need to Know About Kloxxado
Podcast, Volume , Number ,
https://www.thecarlatreport.com///
On April 30th of this year, the FDA approved Kloxxado, a naloxone nasal spray that contains 8mg of naloxone per dose, which is twice as much as the most common formulation: Narcan. But what distinguishes Kloxxado distinguishes from the many other ways that naloxone is delivered and why was it developed in the first place? Published On: 8/16/2021 Duration: 21 minutes, 01 seconds Articles Referenced: “A New High-Dose Naloxone: Life Saver or Punishment?,” The Carlat Addiction Treatment Report,” July/August 2021; “Naloxone Prescribing,” The Carlat Addiction Treatment Report,” July/August 2021 Got feedback? Take the podcast survey.
Leave A Comment
You must be logged in to post a comment.